Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: A clinical follow up study

Frontiers in Aging Neuroscience

Volumn 6, Issue APR, 2014, Pages

  Menéndez González, Manuel ^a,b   Tavares, Francisco ^a   Zeidan, Nahla ^c   Salas Pacheco, José M ^d   Arias Carrión, Oscar ^e  

^a HOSPITAL ÁLVAREZ BUYLLA   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^e HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

Author keywords

DaTSPECT; Movement Disorders; Parkinson disease; SWEDD; Tremor

Indexed keywords

DOPAMINE TRANSPORTER; IOFLUPANE I 123;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DISEASE CLASSIFICATION; DYSTONIC TREMOR; ESSENTIAL TREMOR; FEMALE; FOLLOW UP; FRAGILE X ASSOCIATED TREMOR ATAXIA SYNDROME; HUMAN; IATROGENIC PARKINSONISM; MALE; MULTISYSTEM ATROPHY; OPSOCLONUS MYOCLONUS SYNDROME; PARKINSON DISEASE; PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY; PSYCHOGENIC PARKINSONISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREMOR; VASCULAR PARKINSONISM;

EID: 84901312035     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00056     Document Type: Article

References (49)

1. Ahmed, Z., Asi, Y. T., Sailer, A., Lees, A. J., Houlden, H., Revesz, T., et al. (2012). The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol. Appl. Neurobiol. 38, 4-24. doi: 10.1111/j.1365-2990.2011.01234.x.
2. Antonini, A., and Isaias, I. U. (2009). Imaging evidence supports a link between essential tremor and Parkinson's disease. Nucl. Med. Commun. 30, 93-94. doi: 10.1097/MNM.0b013e328313e580.
3. Apartis, E., Blancher, A., Meissner, W. G., Guyant-Marechal, L., Maltete, D., De Broucker, T., et al. (2012). FXTAS: new insights and the need for revised diagnostic criteria. Neurology 79, 1898-1907. doi: 10.1212/WNL.0b013e318271f7ff.
4. Asenbaum, S., Pirker, W., Angelberger, P., Bencsits, G., Pruckmayer, M., and Brucke, T. (1998). [123I]beta-CIT and SPECT in essential tremor and Parkinson's disease. J. Neural Transm. 105, 1213-1228.
5. Bajaj, N. P., Gontu, V., Birchall, J., Patterson, J., Grosset, D. G., and Lees, A. J. (2010). Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J. Neurol. Neurosurg. Psychiatry 81, 1223-1228. doi: 10.1136/jnnp.2009.193391.
6. Bajaj, N. P., Wang, L., Gontu, V., Grosset, D. G., and Bain, P. G. (2012). Accuracy of subjective and objective handwriting assessment for differentiating Parkinson's disease from tremulous subjects without evidence of dopaminergic deficits (SWEDDs): an FP-CIT-validated study. J. Neurol. 259, 2335-2340. doi: 10.1007/s00415-012-6495-5.
7. Benitez-Rivero, S., Marin-Oyaga, V. A., Garcia-Solis, D., Huertas-Fernandez, I., Garcia-Gomez, F. J., Jesus, S., et al. (2013). Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 84, 122-129. doi: 10.1136/jnnp-2012-302618.
8. Booij, J., Speelman, J. D., Horstink, M. W., and Wolters, E. C. (2001). The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur. J. Nucl. Med. 28, 266-272. doi: 10.1007/s002590000460.
9. Chabolla, D. R., Maraganore, D. M., Ahlskog, J. E., O'Brien, P. C., and Rocca, W. A. (1998). Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota. Mayo Clin. Proc. 73, 724-727. doi: 10.4065/73.8.724.
10. Chaudhuri, K. R., Buxton-Thomas, M., Dhawan, V., Peng, R., Meilak, C., and Brooks, D. J. (2005). Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases. J. Neurol. Neurosurg. Psychiatry 76, 115-117. doi: 10.1136/jnnp.2004.046292.
11. Cilia, R., Rossi, C., Frosini, D., Volterrani, D., Siri, C., Pagni, C., et al. (2011). Dopamine transporter SPECT imaging in corticobasal syndrome. PLoS ONE 6:e18301. doi: 10.1371/journal.pone.0018301.
12. Cohen, O., Pullman, S., Jurewicz, E., Watner, D., and Louis, E. D. (2003). Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. Arch. Neurol. 60, 405-410. doi: 10.1001/archneur.60.3.405.
13. Defazio, G., Gigante, A. F., Abbruzzese, G., Bentivoglio, A. R., Colosimo, C., Esposito, M., et al. (2013). Tremor in primary adult-onset dystonia: prevalence and associated clinical features. J. Neurol. Neurosurg. Psychiatry 84, 404-408. doi: 10.1136/jnnp-2012-303782.
14. De La Fuente-Fernandez, R. (2012). Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology 78, 696-701. doi: 10.1212/WNL.0b013e318248e520.
15. Deuschl, G., Bain, P., and Brin, M. (1998). Consensus statement of the movement disorder society on tremor. Ad hoc Scientific Committee. Mov. Disord. 13(Suppl. 3), 2-23. doi: 10.1002/mds.870131303.
16. Gerasimou, G., Costa, D. C., Papanastasiou, E., Bostanjiopoulou, S., Arnaoutoglou, M., Moralidis, E., et al. (2012). SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease? Ann. Nucl. Med. 26, 337-344. doi: 10.1007/s12149-012-0577-4.
17. Hallett, M. (2011). Psychogenic parkinsonism. J. Neurol. Sci. 310, 163-165. doi: 10.1016/j.jns.2011.03.019.
18. Hossain, A. K., Murata, Y., Zhang, L., Taura, S., Saitoh, Y., Mizusawa, H., et al. (2003). Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping. Mov. Disord. 18, 697-703. doi: 10.1002/mds.10415.
19. Huang, C., Ravdin, L. D., Nirenberg, M. J., Piboolnurak, P., Severt, L., Maniscalco, J. S., et al. (2013). Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study. Dement. Geriatr. Cogn. Disord. 35, 183-196. doi: 10.1159/000345987.
20. Isaias, I. U., Canesi, M., Benti, R., Gerundini, P., Cilia, R., Pezzoli, G., et al. (2008). Striatal dopamine transporter abnormalities in patients with essential tremor. Nucl. Med. Commun. 29, 349-353. doi: 10.1097/MNM.0b013e3282f4d307.
21. Jacquemont, S., Hagerman, R. J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J. A., et al. (2003). Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am. J. Hum. Genet. 72, 869-878. doi: 10.1086/374321.
22. Klaffke, S., Kuhn, A. A., Plotkin, M., Amthauer, H., Harnack, D., Felix, R., et al. (2006). Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration. Mov. Disord. 21, 1724-1727. doi: 10.1002/mds.21004.
23. Labiano-Fontcuberta, A., and Benito-Leon, J. (2012). [Essential tremor and Parkinson's disease: are they associated?]. Rev. Neurol. 55, 479-489.
24. Lang, A. E., Koller, W. C., and Fahn, S. (1995). Psychogenic parkinsonism. Arch. Neurol. 52, 802-810. doi: 10.1001/archneur.1995.00540320078015.
25. Lang, A. E., and Voon, V. (2011). Psychogenic movement disorders: past developments, current status, and future directions. Mov. Disord. 26, 1175-1186. doi: 10.1002/mds.23571.
26. Lopez-Sendon, J., Mena, M. A., and de Yébenes, J. G. (2013). Drug-induced parkinsonism. Expert Opin. Drug Saf. 12, 487-496. doi: 10.1517/14740338.2013.787065.
27. Lorberboym, M., Treves, T. A., Melamed, E., Lampl, Y., Hellmann, M., and Djaldetti, R. (2006). [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease. Mov. Disord. 21, 510-514. doi: 10.1002/mds.20748.
28. Lorenzo Bosquet, C., Miquel Rodriguez, F., Roca Bielsa, I., Mila, M., Aguade Bruix, S., and Castell Conesa, J. (2004). [Differential diagnosis of parkinsonism using dopamine transporters brain SPECT]. Med. Clin. (Barc.) 122, 325-328. doi: 10.1016/S0025-7753(04)74224-4.
29. Marshall, V. L., Reininger, C. B., Marquardt, M., Patterson, J., Hadley, D. M., Oertel, W. H., et al. (2009). Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT. Mov. Disord. 24, 500-508. doi: 10.1002/mds.22108.
30. Nath, U., Ben-Shlomo, Y., Thomson, R. G., Lees, A. J., and Burn, D. J. (2003). Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 60, 910-916. doi: 10.1212/01.WNL.0000052991.70149.68.
31. Rajput, A., Robinson, C. A., and Rajput, A. H. (2004). Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology 62, 932-936. doi: 10.1212/01.WNL.0000115145.18830.1A.
32. Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard, E., et al. (2009). Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol. 8, 1128-1139. doi: 10.1016/S1474-4422(09)70293-5.
33. Schneider, S. A., Edwards, M. J., Mir, P., Cordivari, C., Hooker, J., Dickson, J., et al. (2007). Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov. Disord. 22, 2210-2215. doi: 10.1002/mds.21685.
34. Schwingenschuh, P., Ruge, D., Edwards, M. J., Terranova, C., Katschnig, P., Carrillo, F., et al. (2010). Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study. Mov. Disord. 25, 560-569. doi: 10.1002/mds.23019.
35. Serrano Vicente, J., Garcia Bernardo, L., Duran Barquero, C., Constantino Silva, A., Infante De La Torre, J. R., Dominguez Grande, M. L., et al. (2009). [Negative predictive value of (123)I Ioflupane SPECT in movement disorders]. Rev. Esp. Med. Nucl. 28, 2-5. doi: 10.1016/S0212-6982(09)70207-1.
36. Sibon, I., and Tison, F. (2004). Vascular parkinsonism. Curr. Opin. Neurol. 17, 49-54. doi: 10.1097/00019052-200402000-00009.
37. Stamelou, M., De Silva, R., Arias-Carrion, O., Boura, E., Hollerhage, M., Oertel, W. H., et al. (2010). Rational therapeutic approaches to progressive supranuclear palsy. Brain 133, 1578-1590. doi: 10.1093/brain/awq115.
38. Surasi, D. S., Peller, P. J., Szabo, Z., Mercier, G., and Subramaniam, R. M. (2013). Dopamine Transporter SPECT Imaging in Parkinson Disease and Dementia. PET Clin. 8, 459-467. doi: 10.1016/j.cpet.2013.08.006.
39. Thanvi, B., Lo, N., and Robinson, T. (2005). Vascular parkinsonism-an important cause of parkinsonism in older people. Age Ageing 34, 114-119. doi: 10.1093/ageing/afi025.
40. Tinazzi, M., Cipriani, A., Matinella, A., Cannas, A., Solla, P., Nicoletti, A., et al. (2012). [(1)(2)(3)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. Schizophr. Res. 139, 40-45. doi: 10.1016/j.schres.2012.06.003.
41. Tinazzi, M., Fasano, A., Di Matteo, A., Conte, A., Bove, F., Bovi, T., et al. (2013). Temporal discrimination in patients with dystonia and tremor and patients with essential tremor. Neurology 80, 76-84. doi: 10.1212/WNL.0b013e31827b1a54.
42. Tolosa, E., Borght, T. V., Moreno, E., and Da, TSCAN Clinically Uncertain Parkinsonian Syndromes Study Group. (2007). Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study. Mov. Disord. 22, 2346-2351. doi: 10.1002/mds.21710.
43. Ubhi, K., Low, P., and Masliah, E. (2011). Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci. 34, 581-590. doi: 10.1016/j.tins.2011.08.003.
44. Vlaar, A. M., De Nijs, T., Kessels, A. G., Vreeling, F. W., Winogrodzka, A., Mess, W. H., et al. (2008). Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes. Eur. Neurol. 59, 258-266. doi: 10.1159/000115640.
45. Vlaar, A. M., Van Kroonenburgh, M. J., Kessels, A. G., and Weber, W. E. (2007). Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol. 7:27. doi: 10.1186/1471-2377-7-27.
46. Williams, D. R., De Silva, R., Paviour, D. C., Pittman, A., Watt, H. C., Kilford, L., et al. (2005). Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128, 1247-1258. doi: 10.1093/brain/awh488.
47. Zgaljardic, D. J., Borod, J. C., Foldi, N. S., and Mattis, P. (2003). A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn. Behav. Neurol. 16, 193-210.
48. Zgaljardic, D. J., and Feigin, A. (2004). Neuroimaging of Parkinson's disease and atypical parkinsonism. Curr. Neurol. Neurosci. Rep. 4, 284-289. doi: 10.1007/s11910-004-0053-1.
49. Zgaljardic, D. J., Foldi, N. S., and Borod, J. C. (2004). Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions. J. Neural Transm. 111, 1287-1301. doi: 10.1007/s00702-004-0178-z.